More Press Releases

View Older Stories View Newer Stories

May 30, 2024 04:05PM Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedreich’s Ataxia
May 30, 2024 04:05PM MP Materials to Participate in the Baird Global Consumer, Technology & Services Conference
May 30, 2024 04:05PM IndyCar Driver Marcus Armstrong to Represent Root Insurance at Detroit Grand Prix
May 30, 2024 04:05PM Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension
May 30, 2024 04:05PM Health Catalyst to Participate in Upcoming Investor Conferences
May 30, 2024 04:05PM nCino to Participate in Upcoming Investor Event
May 30, 2024 04:05PM Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affairs
May 30, 2024 04:05PM BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
May 30, 2024 04:05PM Aura Biosciences to Participate in the Jefferies Global Healthcare Conference
May 30, 2024 04:05PM NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
May 30, 2024 04:05PM QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
May 30, 2024 04:03PM Phreesia Announces First Quarter Fiscal 2025 Results
May 30, 2024 04:03PM Viking Therapeutics to Participate at Upcoming Investor Conferences
May 30, 2024 04:01PM Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future So
May 30, 2024 04:02PM Kidoz Inc. Revenue Growth Continues with US$1,793,071 in Q1 2024
May 30, 2024 04:03PM PATH (NYSE) INVESTIGATION ALERT: BFA Law Announces Investigation into UiPath, Inc., Encourages Investors to Inquire and Learn More After Stock Tumbles Over 34%
May 30, 2024 04:02PM NEW ONLINE TOOL MAPS STATEWIDE CLIMATE COMMITMENT ACT INVESTMENTS
May 30, 2024 04:02PM THE INN AT STONECLIFFE SET TO DEBUT JUNE 2024
May 30, 2024 04:00PM Educational Development Corporation Announces Execution of New Tenant Lease Agreement for Available Space at Hilti Complex
May 30, 2024 04:00PM Cotec Holdings Corp. Files First Quarter 2024 Results With Continued Focus on Operational Roll-Out
May 30, 2024 04:02PM Ardelyx, Inc. Reports Employment Inducement Grants
May 30, 2024 04:02PM Corvus Pharmaceuticals to Present at the Jefferies Global Health Conference
May 30, 2024 04:01PM Health Nut's Iconic Salad Dressings Hit Grocery Stores Nationwide
May 30, 2024 04:01PM GDMining Expands Global Reach - Offers New Mining Facilities and New Contracts Opportunities
May 30, 2024 04:01PM NetApp Reports Fourth Quarter and Fiscal Year 2024 Results
May 30, 2024 04:01PM Liberty Global to Present at the Bank of America C-Suite TMT Conference
May 30, 2024 04:01PM Doximity to Present at the William Blair 44th Annual Growth Stock Conference
May 30, 2024 04:01PM Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences
May 30, 2024 04:01PM Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
May 30, 2024 04:01PM JetBlue to Webcast Fireside Chat at Morgan Stanley Travel & Leisure Conference
May 30, 2024 04:01PM Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential fut
May 30, 2024 04:01PM Korro to Participate in Upcoming June Investor and Scientific Conferences
May 30, 2024 04:01PM Pioneer Receives Notification of Delinquency from Nasdaq
May 30, 2024 04:01PM Verve Therapeutics to Participate in Upcoming Investor Conferences
May 30, 2024 04:01PM Lands’ End Rings Nasdaq Opening Bell to Celebrate 10th Anniversary of its Listing on the Exchange
May 30, 2024 04:01PM Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future
May 30, 2024 04:00PM Ilmor and GM Marine Riverfront Experience Returns for the 2024 Detroit Grand Prix
May 30, 2024 04:00PM Century Communities Announces June Grand Opening in Southwest Las Vegas
May 30, 2024 04:00PM Vistra Announces Plans to Add Up to 2,000 MW of Gas-Fueled Dispatchable Power in ERCOT
May 30, 2024 04:00PM Schwan's Company and State of South Dakota announce future investments in Sioux Falls to support new food production facility
May 30, 2024 04:00PM QYOU Media Reports Record Q1 FY 2024 Results
May 30, 2024 04:00PM New Clean Skincare Brand Purdori Wins Prestigious Global Beauty Awards
May 30, 2024 04:00PM José Andrés Names Sam Bakhshandehpour CEO
May 30, 2024 04:00PM Lifestyle and Apparel Company, RSVLTS, Debuts First Co-Branded Collection with Global Hit Anime "One Piece" Celebrating Series' 25th Anniversary
May 30, 2024 04:00PM Palantir Selected by Chief Digital and Artificial Intelligence Office (CDAO) to Participate in Scaling Data Analytics and AI Capabilities Across the Department of Defense in Support of CJADC2 Strategy
May 30, 2024 04:00PM Softchoice Corporation Reports Annual Meeting Voting Results
May 30, 2024 04:00PM OncoNano Medicine To Present a Trials in Progress Poster for ON-5001 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 30, 2024 04:00PM TaskUs to Present at William Blair 44th Annual Growth Stock Conference on June 5, 2024
May 30, 2024 04:00PM Ultragenyx Announces Positive Top-Line Results from Phase 3 Study of DTX401 Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)
May 30, 2024 04:00PM Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination
View Newer Stories View Older Stories